Eight Roads Ventures
AUM - $5 billion
Topics
News
- Karnataka Plans State-Backed AI University
- Kudankulam Data Leak Exposes Critical Infrastructure Gaps
- IBM Says It Faltered as AI Spending Upends Enterprise Buying
- TCS to Power JFK Airport’s $9.5 Billion New Terminal
- AI Use Rises but Engineering Depth Lags, Nasscom Study Shows
- AI Agents Expose Insurance Blind Spots, Report Says
Eight Roads Venture began investing out of Boston in 1969 as Fidelity Ventures. The firm backed the teams behind early innovators such as MCI, Continental Cablevision, and ATARI. It has now partnered with over 300 companies and investment teams across Asia and Europe. Fidelity’s backing allows the firm to stay focused and flexible in supporting its portfolio companies.
Eight Roads has built one of the broadest healthcare portfolios in India, focusing on sectors such as pharmaceuticals, medical devices, diagnostics, healthcare delivery, and health technology. It has supported many growth and late-stage startups with a global presence. The firm leverages its international network and patient capital to help scale companies across India, China, Japan, Europe, and the US.
Eight Roads Ventures has been investing in India since 2007, with a focus on healthcare, technology, consumer, fintech, and enterprise sectors. The firm manages approximately $1.6 billion in India. Key investments include PharmEasy, BankBazaar, FarEye, Toothsi, and Shadowfax. Eight Roads Ventures has also achieved notable exits in sectors such as SaaS, healthcare, and fintech.
